Anthracycline Dose Intensification in Acute Myeloid Leukemia REPLY

被引：0
|
作者：
Fernandez, Hugo F. [1 ]
Rowe, Jacob M. [2 ]
Tallman, Martin S. [3 ]
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[2] Rambam Med Ctr, Haifa, Israel
[3] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2009年 / 361卷 / 26期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2578 / 2578
页数：1
相关论文
共 50 条
  • [31] Reply to Induction Therapy and Outcome in Acute Myeloid Leukemia
    Rowe, Jacob M.
    Kim, Haesook T.
    Tallman, Martin S.
    CANCER, 2011, 117 (10) : 2237 - 2237
  • [32] AGE AND THE BIOLOGY OF ACUTE MYELOID-LEUKEMIA - REPLY
    HEINEMANN, V
    JEHN, U
    ANNALS OF HEMATOLOGY, 1992, 64 (03) : 158 - 159
  • [33] Oral Azacitidine Maintenance for Acute Myeloid Leukemia Reply
    Wei, Andrew H.
    Doehner, Hartmut
    Roboz, Gail J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (13):
  • [34] Commentary: dose intensive chemotherapy in acute myeloid leukemia
    Feldman, EJ
    LEUKEMIA RESEARCH, 2001, 25 (03) : 217 - 219
  • [35] INTENSIFICATION OF ANTHRACYCLINE DURING INDUCTION AND CONSOLIDATION IS SAFE AND WELL TOLERATED IN OLDER PATIENTS WITH ACUTE MYELOID LEUKAEMIA
    Loh, J.
    Avery, S.
    Patil, S.
    Walker, P.
    Spencer, A.
    Wei, A.
    Fleming, S.
    HAEMATOLOGICA, 2017, 102 : 381 - 382
  • [36] Incidence and predictors of anthracycline-related left ventricular dysfunction in acute myeloid leukemia
    Stahl, Maximilian
    Giblin, Gerard
    Liu, Yiwen
    Winer, Eric S.
    Garcia, Jacqueline S.
    Chen, Evan
    Wadleigh, Martha
    Ling, Kelly
    Lindsley, R. Coleman
    Shimony, Shai
    Copson, Kevin
    Charles, Anne
    DeAngelo, Daniel J.
    Stone, Richard M.
    Nohria, Anju
    Luskin, Marlise R.
    LEUKEMIA RESEARCH, 2023, 132
  • [37] CURATIVE IMPACT OF INTENSIFICATION WITH HIGH-DOSE CYTARABINE (HIDAC) IN ACUTE MYELOID-LEUKEMIA (AML) VARIES BY CYTOGENETIC GROUP
    BLOOMFIELD, CD
    LAWRENCE, D
    ARTHUR, DC
    BERG, DT
    SCHIFFER, CA
    MAYER, RJ
    BLOOD, 1994, 84 (10) : A111 - A111
  • [38] Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype
    Bloomfield, CD
    Lawrence, D
    Byrd, JC
    Carroll, A
    Pettenati, MJ
    Tantravahi, R
    Patil, SR
    Davey, FR
    Berg, DT
    Schiffer, CA
    Arthur, DC
    Mayer, RJ
    CANCER RESEARCH, 1998, 58 (18) : 4173 - 4179
  • [39] Pre-anthracycline echocardiogram rarely changes treatment strategy in acute myeloid leukemia
    Ogden, John
    Yui, Jennifer
    Ali, Walid
    Mudireddy, Mythri
    Al-Kali, Aref
    Patnaik, Mrinal
    Gangat, Naseema
    Elliott, Michelle
    Hogan, William
    Hook, Christopher
    Wolanskyj-Spinner, Alexandra
    Pardanani, Animesh
    Villarraga, Hector
    Litzow, Mark
    Tefferi, Ayalew
    Begna, Kebede
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (06) : E144 - E146
  • [40] Anthracycline cardiotoxicity in patients with acute myeloid leukemia: cardiovascular risk assessment, monitoring and management
    Morelli, O.
    Pasvolsky, O.
    Vaturi, M.
    Vaxman, I.
    Amitai, I.
    Raanani, P.
    Kornowski, R.
    Iakobishvili, Z.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1306 - 1306
12345